SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
1352458507083444v1
14/3/415    most recent
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Le Scanff, J.
Right arrow Articles by Vukusic, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Scanff, J.
Right arrow Articles by Vukusic, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Uveitis associated with multiple sclerosis

Julie Le Scanff

Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France

Pascal Sève

Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France, pascal.seve{at}chu-lyon.fr

Christel Renoux

Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France

Christiane Broussolle

Department of Internal Medicine, Hospices Civils de Lyon, Hotel Dieu, 1 place de l'Hôpital, 69288 Lyon Cedex 02, France and University Claude Bernard Lyon 1, Lyon, France

Christian Confavreux

Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France

Sandra Vukusic

Department of Neurology A and EDMUS Coordinating Center, Hôpital Neurologique, Hospices Civils de Lyon, Lyon, France, Université Lyon 1, Lyon, France, INSERM U842, Lyon, France

Our study aimed to determine the frequency of uveitis among MS patients through the Lyon MS Database and compare the clinical spectrum and time course of MS in patients with or without uveitis. Twenty-eight patients with uveitis were detected. The prevalence of uveitis in our population was 0.65% (28/4300). Uveitis preceded onset of MS in 46% of the patients; it occurred simultaneously or after MS, in 18% and 36% of the cases, respectively. The topography and timing of uveitis were not associated with any significant difference in MS course and prognosis. There was no difference in the course and prognosis in patients with or without uveitis. Multiple Sclerosis 2008; 14: 415—417. http://msj.sagepub.com

Key Words: multiple sclerosis • uveitis

This version was published on April 1, 2008

Multiple Sclerosis, Vol. 14, No. 3, 415-417 (2008)
DOI: 10.1177/1352458507083444
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement